Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TIPS and hepatic encephalopathy

G Pomier-Layrargues1

  • 1Liver Unit, André-Viallet Clinical Research Center, Hôpital Saint-Luc, Université de Montréal, Canada.

Seminars in Liver Disease
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved survival after liver transplantation in patients with hepatopulmonary syndrome.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C.

Neurogastroenterology and motility·2008
Same author

Usefulness of transjugular intrahepatic portosystemic shunt in the management of bleeding ectopic varices in cirrhotic patients.

Cardiovascular and interventional radiology·2005
Same author

Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy.

The American journal of gastroenterology·2001
Same author

Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.

Gut·2001
Same author

Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.

Hepatology (Baltimore, Md.)·2000
Same journal

Endothelial Cell Therapy for the Acute and Chronic Liver Disease.

Seminars in liver disease·2026
Same journal

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Seminars in liver disease·2026
Same journal

Expert Practical Recommendations for Hepatocellular Carcinoma.

Seminars in liver disease·2026
Same journal

Optimizing Liver Cancer Care Through BCLC Principles.

Seminars in liver disease·2026
Same journal

Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.

Seminars in liver disease·2026
Same journal

Practical Guide to Best Practices in Alcohol-Associated Liver Disease.

Seminars in liver disease·2026
See all related articles

Transjugular intrahepatic portosystemic shunts (TIPS) require reassessment for portal hypertension complications. Post-TIPS encephalopathy is significant, necessitating careful patient selection and monitoring for optimal treatment.

Area of Science:

  • Hepatology
  • Interventional Radiology
  • Gastroenterology

Background:

  • Transjugular intrahepatic portosystemic shunt (TIPS) is increasingly used for portal hypertension complications.
  • Collective global experience necessitates a reassessment of its efficacy and risks.

Purpose of the Study:

  • To re-evaluate the role and indications of TIPS in managing portal hypertension.
  • To define the optimal balance between portal decompression and liver perfusion.
  • To minimize adverse effects like hepatic encephalopathy and liver failure.

Main Methods:

  • Review of collective clinical experience from multiple centers worldwide.
  • Analysis of post-TIPS outcomes, including encephalopathy and shunt patency.
  • Emphasis on the need for well-designed clinical trials.

Related Experiment Videos

Main Results:

  • Post-TIPS hepatic encephalopathy (HE) rate is significant, comparable to surgical shunts.
  • Reduced HE incidence during follow-up often results from shunt stenosis and recurrence of portal hypertension.
  • Shunt stenosis can lead to ascites and variceal bleeding recurrence.

Conclusions:

  • TIPS should be considered one among several treatment options for portal hypertension.
  • Early shunt closure is advised for disabling encephalopathy or liver failure, with alternatives like transplantation.
  • Further prospective studies are crucial to optimize TIPS use in cirrhotic patients.